| Autor: |
Wouthuyzen-Bakker, Marjan, Sebillotte, Marine, Lomas, Jose, Kendrick, Benjamin, Palomares, Eva Benavent, Murillo, Oscar, Parvizi, Javad, Shohat, Noam, Reinoso, Javier Cobo, Sánchez, Rosa Escudero, Fernandez-Sampedro, Marta, Senneville, Eric, Huotari, Kaisa, Allende, José Maria Barbero, García, Antonio Blanco, Lora-Tamayo, Jaime, Ferrari, Matteo Carlo, Vaznaisiene, Danguole, Yusuf, Erlangga, Aboltins, Craig |
| Zdroj: |
Journal of Infection; Sep2019, Vol. 79 Issue 3, p199-205, 7p |
| Abstrakt: |
Objectives: We evaluated the treatment outcome in late acute (LA) periprosthetic joint infections (PJI) treated with debridement and implant retention (DAIR) versus implant removal.Methods: In a large multicenter study, LA PJIs of the hip and knee were retrospectively evaluated. Failure was defined as: PJI related death, prosthesis removal or the need for suppressive antibiotic therapy. LA PJI was defined as acute symptoms <3 weeks in patients more than 3 months after the index surgery and with a history of normal joint function.Results: 445 patients were included, comprising 340 cases treated with DAIR and 105 cases treated with implant removal (19% one-stage revision (n = 20), 74.3% two-stage revision (n = 78) and 6.7% definitive implant removal (n = 7). Overall failure in patients treated with DAIR was 45.0% (153/340) compared to 24.8% (26/105) for implant removal (p < 0.001). Difference in failure rate remained after 1:1 propensity-score matching. A preoperative CRIME80-score ≥3 (OR 2.9), PJI caused by S. aureus (OR 1.8) and implant retention (OR 3.1) were independent predictors for failure in the multivariate analysis.Conclusion: DAIR is a viable surgical treatment for most patients with LA PJI, but implant removal should be considered in a subset of patients, especially in those with a CRIME80-score ≥3. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full Text from ScienceDirect